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To identify the most important factors that impact brain volume, while accounting for potential 
collinearity, we used a data-driven machine-learning approach. Gray Matter Volume (GMV) was derived 
from magnetic resonance imaging (3T, FLAIR) and adjusted for intracranial volume (ICV). 93 potential 
determinants of GMV from the categories sociodemographics, anthropometric measurements, 
cardio-metabolic variables, lifestyle factors, medication, sleep, and nutrition were obtained from 293 
participants from a population-based cohort from Southern Germany. Elastic net regression was used to 
identify the most important determinants of ICV-adjusted GMV. The four variables age (selected in each 
of the 1000 splits), glomerular filtration rate (794 splits), diabetes (323 splits) and diabetes duration 
(122 splits) were identified to be most relevant predictors of GMV adjusted for intracranial volume. 
The elastic net model showed better performance compared to a constant linear regression (mean 
squared error = 1.10 vs. 1.59, p < 0.001). These findings are relevant for preventive and therapeutic 
considerations and for neuroimaging studies, as they suggest to take information on metabolic status 
and renal function into account as potential confounders.
A plethora of factors such as cardiovascular, metabolic and lifestyle parameters influence gray matter (GM) vol-
ume (GMV) of the human brain, with partially overlapping and intercorrelated and partially differential effects.
Among all the potential determinants of GMV, age is probably the best-established factor. There is consensus 
that a certain decrease of GMV can be considered as a normal function of aging1,2. As such, it is common practice 
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to account for age as a cofactor when analyzing volumetric neuroimaging data3,4. Previous population-based 
studies have also identified several other factors that contribute to GMV loss, e.g. reporting negative correlations 
between GMV and alcohol consumption5, (pre-)diabetes6, cardiovascular risk factors such as hypertension7 and 
obesity8, as well as low levels of physical activity9.
These factors usually do not occur isolated but as a combination of multiple risk factors that determine atro-
phy patterns and rates. Also, diabetes, the metabolic syndrome and alcohol abuse are not dichotomous entities 
but range within a broad spectrum, defined by multiple parameters such as blood test results, clinical test results, 
and imaging parameters. Given this broad spectrum of potential risk factors, drawing a clear picture of the most 
powerful determinants of GMV and atrophy is challenging. While a single factor might be associated with GMV 
in univariate regression analysis, it is often unclear how important this factor is compared to other parameters 
that impact GMV.
An exploratory, data-driven approach might be able to not only confirm previously described associated fac-
tors influencing GMV, but also provide an estimate about their relative importance and help to identify addi-
tional determinants. While traditional confounder-adjusted regression models have limitations when it comes 
to datasets with a large number of predictors in relation to sample size and potential collinearity of variables, a 
machine-learning approach may be able to overcome these limitations. For example, the Elastic Net (EN) is a 
method for variable selection that can select the most important factors from a large pool even in the presence of 
collinearity10.
We analyzed a study sample from a cross-sectional case-control study nested within a prospective 
population-based cohort without overt cardiovascular disease from the Cooperative Health Research in the 
Region of Augsburg (KORA) in Southern Germany. Leveraging this rich and unique dataset, we applied multi-
variate machine-learning algorithms using EN regression to determine potential determinants of intracranial vol-
ume (ICV)-adjusted GMV across normoglycemic subjects, subjects with prediabetes and subjects with diabetes.
Material and Methods
Study design and participants. We used data from the population-based KORA FF4 study (2013–2014, 
2,279 participants). The FF4 study is the second follow-up of subjects that participated in the baseline study 
(KORA S4, 1999–2001, 4,261 participants). Study design, recruitment of participants and data collection of the 
KORA studies have been described in detail elsewhere11. Nested within the FF4 KORA study, a whole-body 
magnetic resonance imaging (MRI) sub-study was conducted (n = 400, age 39–73 years) following a case-control 
design with 54 subjects with diabetes, 103 with prediabetes and 243 with normal glucose metabolism. Inclusion 
and exclusion criteria for the MRI examination have been described previously12. Briefly, subjects with a history 
of stroke, myocardial infarction and arterial vessel occlusion, type 1 diabetes mellitus or contraindications to 
MRI were excluded. To avoid bias from neuropsychiatric disease that might effect brain volume we also excluded 
patients with depressive symptoms and antiepileptic/psychiatric medication. In total, 107 subjects had to be 
excluded (see flowchart Fig. 1). All subjects underwent MRI within 3 months after their clinical examination 
at the study center with a median time between the clinical examination and the MRI of 33 days (interquartile 
range 24–45 days). The majority of MRI exams (67%) were acquired before noon. All study participants gave writ-
ten informed consent. The study was approved by the ethics committee of the Bavarian Chamber of Physicians 
and the ethics committee of the Ludwig-Maximilians-University Munich and complies with the Declaration of 
Helsinki.
Figure 1. Flowchart of participant selection. PHQ = patient health questionnaire.
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Image acquisition. Fluid-attenuated inversion recovery (T2w FLAIR 3D) sequences of the brain were 
acquired in supine position using a 3 Tesla MRI scanner (Magnetom Skyra (software syngo MR D13C), Siemens 
AG, Healthcare Sector, Erlangen, Germany) with a 20-channel phased-array head and neck coil. For all subjects, 
the same scanner, with no upgrade or software change, was used. The following parameters were used for image 
acquisition: ST = 0.9 mm, Voxel size inplane = 0.5 ×0.5 mm2, field of view (FOV) = 245 ×245 mm, matrix 256 
×256, repetition time (TR) = 5000 ms, echo time (TE) = 389 ms, TI = 1800 ms, flip angle = 120°, and have also 
previously been described elsewhere12.
Structural brain MRI processing and volumetry. Volumetric GM measurements used for the pres-
ent study were obtained using a warp-based automated brain volumetric approach based on FLAIR MRI data. 
T1-weighted images of the brain were not acquired in the KORA-MRI study due to time constraints arising from 
the whole-body MRI protocol. We have therefore validated FLAIR-based brain volumetry in a recently published 
study by Beller et al. that assessed the feasibility of this approach by correlating the results of FLAIR-based and 
T1-based volumetry results of 116 atlas regions in 30 healthy individuals13.
Processing of the FLAIR brain MRI data for the present analysis followed the steps described in the 
above mentioned method paper on the feasibility of FLAIR-based GM volumetry13: See Fig. 2 for an overview of 
the general approach.
Warp-based, automated brain segmentation was applied. Images were pre-processed using FSL 5.0.9 (http://
www.fmrib.ox.ac.uk/fsl/index.html) and AFNI (Analyses of Functional Images, http://afni.nimh.nih.gov/afni). 
Firstly, Fsl2standard (FSL) was used to reorient FLAIR images to match the orientation of the standard template 
(MNI152). Secondly, the brain was extracted from the re-aligned FLAIR images using the brain extraction tool 
(BET) implemented in FSL14. For brain segmentation into GM, white matter (WM), and cerebrospinal fluid (CSF) 
FAST (FMRIB’s Automated Segmentation Tool) was used14. Individual images were warped onto the Automatic 
Anatomical Labeling (AAL) atlas15 in MNI standard space, applying linear and non-linear registration as imple-
mented in FLIRT and FNIRT16. For each individual subject, volumetric data for total GM, WM, CSF, and 116 atlas 
regions (45 cortical and subcortical regions in each hemisphere, and 26 cerebellar regions17) were calculated. To 
adjust for differences in head size, ratio-corrected brain volumes were calculated by dividing the original uncor-
rected volume by total intracranial volume (defined as the sum of GM, WM and CSF)18,19. See Supplementary 
Figure 1 for a scatter plot showing the relationship between GMV and ICV. This approach resulted in the final 
outcome variable for further analysis: ICV-adjusted whole-brain GMV (as a percentage of intracranial volume). 
The researcher who performed the preprocessing and volumetric analyses (D.K.) was blinded to all potential 
determinants of ICV-adjusted GMV.
For the analyses of determinants of GMV in the present study, only GM structures that showed a significant 
correlation between the volumetric results of T1- versus FLAIR-based imaging in the abovementioned validation 
study13 were included. Beller et al. considered a Spearman rank correlation coefficient ≥0.597, corresponding to 
a p-value < 0.0005 between T1- and FLAIR-based GM volume as significant (please see Supplementary Table 1 
for an overview of the structures used in the current study)13.
Potential determinants of GMV. To assess the potential influence of variables on ICV-adjusted GMV, 93 
predictor variables from the following categories were used: sociodemographics, anthropometric measurements, 
MRI-derived hepatic and visceral fat, diabetes-related variables, lifestyle factors, somatic symptoms, medica-
tion, blood pressure, sleep, laboratory values and nutrition. Sociodemographic variables (e.g. age, family status, 
education, income), somatic symptoms, medication intake, sleep-related variables (e.g. duration, sleeping prob-
lems) were assessed using standardized interviews and questionnaires (please see Supplementary Materials and 
Supplementary Table 2 for a detailed description of variables and references).
Descriptive statistics. Continuous predictor variables and ICV-adjusted GMV are presented as either mean 
and standard deviation (SD) or median with first and third quartile, where appropriate. Categorical predictor 
Figure 2. Overview of gray matter volumetry. FLAIR images of each individual (A) were reoriented and 
brain-extracted (B). The brain was segmented into gray matter (C), white matter and cerebrospinal fluid. Each 
individuals binarized gray matter map was warped onto the Automatic Anatomical Labeling atlas in MNI space 
(D) using linear and non-linear registration.
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variables are presented as counts and percentages. For a description of how missing data were handled, please see 
Supplemental Materials and Supplementary Table 3.
Elastic net regression. For outcome ICV-adjusted GMV, a linear EN regression10 was calculated using all 
predictor variables presented in Supplementary Table 4 simultaneously. EN regression is a method for variable 
selection. The added value of this method compared to traditional linear regression models stems from its ability 
to provide further information on relative variable importance. This method may be deemed especially helpful 
for a data-driven analysis of large datasets with multiple, potentially predictive variables with differential impact. 
While collinearity poses a significant statistical challenge for traditional regression methods, the EN regression 
selects variables based on their relative importance, even in the presence of collinearity.
EN incorporates the features of both Ridge and least absolute shrinkage and selection operator (LASSO) 
regression. In Ridge regression (equivalent to a hyperparameter α = 0 in the calculation of the EN), variable 
coefficients cannot be shrunk to 0, therefore all variables are forced to stay in the model. In LASSO regression 
(equivalent to a hyperparameter α = 1 in the calculation of the EN), variable coefficients can be shrunk to 0 and 
therefore variable selection can be performed. By tuning the hyperparameter α, an appropriate amount of varia-
ble selection can be achieved.
As there are no established criteria for choosing the best value of the hyperparameter α, it is common to per-
form the analysis on a grid of sensible α values while minimizing a performance criterion specified a-priori. We 
minimized the mean squared error (MSE), calculated as MSE = (1/N) * Σ(predicted values – true values)2. The 
root of MSE is on the same scale as the outcome and denotes how many units predicted and actual outcome differ, 
i.e. a lower root of MSE is indicative of a better ability of the EN to predict the outcome.
We performed all calculations on a grid of α values ranging from α = 0 (Ridge regression) to α = 0.2 in incre-
ments of 0.01. Results are presented for α = 0.2, as this α level showed the best tradeoff between parsimonity (at 
higher α levels and full LASSO, variable selection was too strict to provide an informative model) and prediction 
performance (at lower α levels, prediction performance as measured by MSE was worse). For an exemplary graph 
of the influence of changing α values on number of selected splits and β-coefficients see Supplementary Figure 2.
We generated 1000 random data splits. For each data split, the original full data set (N = 293) was divided 
into 90% (N = 264, respectively) training data and 10% (N = 29, respectively) testing data. Note that due to the 
different random splitting, the distribution of the original full data set into training and test set is different for 
each single split of the 1000.
On each of the 1000 training sets, the shrinkage parameter λ was calculated by internal 10-fold 
cross-validation. This corresponds to a first, inner, cross-validation loop for hyperparameter optimization20. With 
the determined λ value, the linear model with EN penalization was fitted on the full corresponding training 
data set. The resulting models contain only a subset of the original variables, as coefficients of some variables are 
shrunk to zero. As a measure of relative variable importance, we report the percentage how often a variable was 
selected over the 1000 data splits. Furthermore, we report the β-coefficients averaged over 1000 splits for those 
variables that were selected.
For each of the 1000 data splits, the model derived on the training data set was then applied to the respective 
held-out test data set, which corresponds to a second, outer, validation loop20. By applying the model to the test 
data set, we obtained predicted values of the outcome GMV. We then calculated the MSE, as a criterion of predic-
tion performance, as well as adjusted R2 as a measure of outcome variance explained. We report MSE and adjusted 
R2 averaged over 1000 data splits.
Estimated coefficients from the fitted EN regression are biased towards zero due to the shrinking procedure. 
Conventional statistical inference, including the calculation of confidence intervals and p-values is therefore not 
possible. Alternative methods to calculate p-values have not been rigorously established for EN methods and are 
therefore not reported here.
This also complicates the comparison to unpenalized linear models. Due to the bias in shrunken coefficients21, 
a direct model comparison, including β-coefficients and benchmark metrics, of EN regression and unpenalized 
regression is not meaningful. For comparison, we therefore used the Null Model, which includes no covariates 
and always predicts the mean GMV of the sample. It can thus be considered as the minimum bound of predictive 
performance: Any model that performs worse than this Null Model is not suitable for improving our knowledge 
about potential predictors of GMV. The Null Model was calculated analogously to the main EN model on all 1000 
data splits of training and test data.
To further explore the added value of the variables identified by EN regression, we additionally calculated 
unpenalized regression models a) including the relevant predictor variables identified by EN regression b) includ-
ing only age as a predictor variable. For these unpenalized models, 1000 new random data splits of training and 
testing data were created, again in a 90% to 10% ratio. Unpenalized linear models a) and b) were fitted on the 
training data. A likelihood-ratio test was computed to test which model fits the data better. Then, models a) and 
b) were applied to the test data to obtain MSE and R2. These metrics can be compared between model a) and b), 
as both stem from unpenalized regression. We report MSE and adjusted R2 averaged over 1000 data splits. The 
p-values from 1000 Likelihood-Ratio-Tests are displayed by a histogram.
This routine leads to overoptimistic models. Although the data split, and thereby the training and testing data, 
is different from the one that was used to derive the EN model, the underlying data set is still the same. Hence, the 
unpenalized regression models using the predictors identified by EN regression are expected to perform better 
than they would perform on an independent data set. This routine is therefore not recommended to describe the 
performance of the identified predictors in absolute terms. However, regression models a) and b) are likewise 
affected by this overoptimism and thus comparison between those two is possible.
As an additional follow-up, correlations between the variables that were identified by EN regression and GMV 
volume were calculated by permutation tests on 20 000 simulations.
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All analyses were conducted with R version 3.4.1. We used package MICE v2.30 for imputation22, package 
glmnet 2.0–1323 for the calculation of EN regression and package jmuOutlier 2.2 for permutation testing.
Results
Participants. Of 400 subjects from the KORA MRI sub-study, 293 subjects fulfilled the eligibility criteria and 
were included in the analysis. Baseline characteristics are described in Supplementary Table 4. Briefly, the sample 
consisted of 59% men, had a mean age of 55.4 ± 9.1 years; 11.9% had diabetes, 23.2% were categorized as subjects 
with prediabetes and 64.8% had a normal glycemic status.
The mean ICV-adjusted GMV was 20.5% ± 1.3 (see Fig. 3 for the distribution of ICV-adjusted GMV meas-
urements) and mean ICV-adjusted GMV did not show significant differences based on when during the day the 
MRI was acquired (p = 0.646), see Supplementary Table 5 for details.
Determinants of ICV-adjusted gray matter volume. The following four variables were identified to 
be the most predictive (selected in at least 100/1000 splits) of ICV-adjusted GMV: age (selected in each split 
(1000/1000)), GFR (794 splits), diabetes (323 splits) and diabetes duration (122 splits, see Fig. 4). The MSE of 
the ICV-adjusted GMV EN regression model (MSE = 1.1015, α = 0.02, mean λ averaged over 1000 splits = 1.08, 
adjusted R2 averaged over 1000 splits = 31%) was lower than the MSE of the Null model (mean ICV-adjusted 
GMV without adjusting for any cofactors, MSE0 = 1.5858), which serves as a proof-of-concept that the EN model 
provides additional explanatory value of ICV-adjusted GMV. For a detailed overview of selected variables please 
see Supplementary Table 6A, for performance measures of the EN regression see Supplementary Table 6B. In 
unpenalized regression models, the model including age, GFR, diabetes and diabetes duration fit the data signifi-
cantly better than the model including age only (see histogram of p-values in Supplementary Figure 3), provided 
a slightly better MSE and explained more variance in GMV (see Supplementary Table 7).
While nutrition variables were initially included in the 93 potential determinants of ICV-adjusted GMV, they 
were not included in the main analyses due to the high number of missing values. To evaluate the influence of 
nutrition variables, we performed sensitivity analyses only using data from participants where nutrition data was 
available. In these complete-cases analyses, no nutrition variable was selected for any outcome. Sensitivity anal-
yses were also performed to evaluate a potential influence of prediabetes on ICV-adjusted GMV when excluding 
Figure 3. Histogram of ICV-adjusted GMV. ICV = intracranial volume, GMV = gray matter volume.
Figure 4. Bar diagram of most important determinants of ICV-adjusted GMV. The left-sided y-axis (bar height) 
shows the selection frequency in % of 1000 splits where the corresponding variable was selected (α = 0.2), only 
variables selected in >100 splits are shown. The right-sided axis provides information about the beta coefficient 
(diamond symbol within bars). ICV = intracranial volume, GMV = gray matter volume, MSE = mean squared 
error, MSE0 = MSE of the Null Model.
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all subjects with established type-2 diabetes. However, prediabetes was also not selected as a predictor variable in 
these sensitivity analyses.
For ICV-adjusted GMV, age and GFR were selected in the highest number of splits. Figure 5 shows the 
correlation between these two variables and ICV-adjusted GMV. With increasing age, ICV-adjusted GMV 
decreases (Pearson’s r = −0.67, 95% Confidence Interval [−0.73, −0.60], permutation-based p-value <0.001). 
ICV-adjusted GMV was positively correlated with kidney function (Pearson’s r = 0.37, 95%-CI [0.26, 0.46], 
permutation-based p-value < 0.001). Additionally, diabetes and diabetes duration were selected as predictive 
variables of ICV-adjusted GMV. Indeed, ICV-adjusted GMV was lower in participants with diabetes compared 
to normoglycemic subjects (19.7% ± 1.6 vs 20.6% ± 1.2, permutation-based p-value < 0.001), see Fig. 6A. There 
was no significant difference in ICV-adjusted GMV between subjects with normal glycemic status and those with 
prediabetes (20.6% ± 1.2 vs 20.7% ± 1.2. p = 1.00). Figure 6B illustrates the decreasing ICV-adjusted GMV with 
duration of diabetes (Pearson’s r = −0.15, permuation-based p-value = 0.008).
Discussion
Applying a data-driven, exploratory machine-learning approach, we analyzed a rich dataset from the KORA study 
and identified age, kidney function, glycemic status and diabetes duration as the most predictive determinants of 
ICV-adjusted GMV. We could show that EN regression is a feasible approach of leveraging rich population-based 
datasets to identify and rank predictors from a large pool of variables that impact outcomes such as ICV-adjusted 
GMV.
Following age, kidney function (indicated by GFR), glycemic status, and diabetes duration were selected as 
the most predictive variables for ICV-adjusted GMV. Although it has been well known that total GMV declines 
as a function of age1,2 our study extends this knowledge, by putting the impact of age into perspective to the 
impact of many other potential predictors of GMV. Among these other factors, kidney function was revealed 
as an important predictor of ICV-adjusted GMV. Changes in GFR have been identified as an early indicator of 
diabetic nephropathy24, a common complication among patients with diabetes. As patients with reduced kid-
ney function often display further risk factors of cerebral changes such as diabetes and hypertension, the exact 
Figure 5. Correlation between ICV-adjusted GMV and (A) Age, (B) Glomerular Filtration rate. 
ICV = intracranial volume, GMV = gray matter volume.
Figure 6. (A) Boxplot of ICV-adjusted GMV and glycemic status. (B) ICV-adjusted GMV and duration of 
diabetes. Displayed are mean and standard deviation in the respective groups. ICV = intracranial volume, 
GMV = gray matter volume.
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mechanism of how reduced kidney function – after adjusting for other risk factors – may lead to structural brain 
changes, has not been fully understood25. One hypothesis being discussed is that cerebral small vessel disease 
leads to white matter hyperintensities among patients with chronic kidney disease26. Accordingly, several studies 
have have found an association between reduced GFR/chronic kidney disease and increased white matter hyper-
intensities27,28. GMV loss has also been found in patients with end stage renal disease, discussing elevated serum 
urea levels as a potential risk factor29.
Our results of diabetes-related variables among the top contributing factors of ICV-adjusted GMV confirm 
findings from prior studies showing reduced GMV among subjects with diabetes compared to healthy con-
trols (for meta-analysis, see30). However, the detailed pathophysiology of the association between diabetes and 
decreased GMV remains unclear. Potential key factors that have been discussed are detrimental effects of per-
manently elevated glucose levels and resulting brain insulin resistance. Chronic hyperglycemia has been found 
to cause accumulation of proinflammatory advanced glycosylation end products which may lead to irreversible 
tissue damage31,32. Brain insulin resistance has been shown to cause impaired synaptogenesis, altered synaptic 
plasticity, mitochondrial dysfunction and increased tau phosphorylation33. Accordingly, the cortical atrophy pat-
terns among patients with diabetes partially resemble those in preclinical Alzheimer disease34.
Our findings suggest that other variables, like prediabetes, gender and hypertension may carry relatively less 
predictive value. Despite the strong impact of diabetes on ICV-adjusted GMV found in this study, prediabetes 
was not selected as one of its most important predictors, neither in our intial machine-learning approach, nor 
in a subsequent sensitivity analysis where subjects with type 2 diabetes mellitus were excluded. At first glance, 
this result might seem to contradict previous reports of reduced GMV in prediabetic subjects6. However, the dis-
crepancy may be partially explained by differences between an hypothesis-driven approach and our data-driven, 
exploratory analysis. While our results do not rule out a potential association between prediabetes and GMV, they 
merely suggest that other variables from our large pool of potential determinants of GMV are more important for 
the prediction of ICV-adjusted GMV in our study population without overt cardiovascular disease.
While associations between gender and GMV have been previously reported3, gender was not selected as one 
of the most important determinants of ICV-adjusted GMV in our study, and there was no significant difference of 
ICV-adjusted GMV between men (20.5±SD 1.3) and women (20.6±SD 1.2, p = 0.316), see Supplementary Figure 
4. As our sample size was already limited, we refrained from sex-stratified analyses to maintain statistical power. 
Analogously, the fact that other previously described determinants of GMV, such as elevated glycated hemoglobin 
(HbA1c)35 and hypertension7, were not selected in our analyses, might be rooted in the design of our analysis, 
which aimed at identifiying only the most powerful among various factors. While hypothesis-driven neuroimag-
ing studies often do not account for metabolic factors such as type 2 diabetes or hypertension36, our data-driven 
analysis included 93 variables. Alleged discrepancies between our study results and previous findings have to be 
interpreted in consideration of this fundamentally different study design and aim.
Neuroimaging studies investigating volumetric changes in aging and neurodegeneration usually control for 
age and gender, e.g.37,38. Additional metabolic, renal and cardiovascular parameters are mostly not assessed. While 
our results underline the importance of controlling for age, they also suggest that information on diabetes and 
renal function should be collected and taken into account when analyzing and interpreting neuroimaging data.
As the KORA-MRI sub-study focused on individuals without overt cardiocerebrovascular disease39, the study 
sample is not entirely representative of the general population. Participants with prediabetes and diabetes are 
likely to be over-represented in this cohort which may have favored the selection of diabetes-related variables 
based on the increased power to detect a diabetes-related effect. In addition, we used volumetric data derived 
from FLAIR images instead of a T1-weighted images of the brain. While the feasibility of FLAIR-based brain 
volumetry has been assessed in healthy individuals13, T1 images are the standard for structural brain analyses. As 
such, some differences between our findings and previous results may also be a result of sequence-specific dif-
ferences in brain segmentation. However, by only including GM structures in our ICV-adjusted GMV that have 
been reported to show significant correlations between T1- and FLAIR-based volumetry results we obtained at a 
FLAIR-based ICV-adjusted GMV that can serve as a proxy of GMV.
Our statistical machine-learning model identified important covariates by optimizing prediction perfor-
mance. It is not a formal causal inference model; therefore we cannot claim that the identified predictors are etio-
logic factors or have causal effects on GMV. To assess causality in a formalized way, other statistical methods have 
to be used. However, especially for cross-sectional, observational data, these formal methods of causal inference 
require extensive theoretical reasoning and strong assumptions of the underlying etiologic structures. Particularly 
in an epidemiological context it is important to consider evidence from a variety of models and study designs to 
explore causality40,41. Therefore, although our model is not causal in the formalized sense, it can still inform causal 
theory and provide important indications for potential etiologic factors of GMV.
Given the limitations of our study, external validation of our approach using data from other large 
population-based studies such as UK Biobank42 with available brain imaging (including T1-weighted brain 
images) data, as well as evaluating the influence of different brain parcellation schemes and different machine 
learning approaches would be beneficial.
conclusions
In conclusion, this study shows that EN regression is a feasible machine-learning approach to identify predictors 
of ICV-adjusted GMV. The results from this data-driven exploratory analysis could potentially generate hypoth-
eses for more focused, hypothesis-driven studies to follow. Additionally, the identification of diabetes-related 
parameters and GFR as important predictive variables for GMV suggests that these parameters should be taken 
into account in neuroimaging studies, especially when investigating effects of aging and neurodegeneration.
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